vcvibes

Mesa Verde Venture Partners

Emerging manager

Built from this firm's Form D filings. The firm files no SEC adviser report.

HQ
CA

Mesa Verde Venture Partners is an early-stage life sciences venture capital firm that aims to build partnerships with entrepreneurs to grow successful companies. Its team includes managing directors Carey Ng, Fred Middleton, and Francois Ferre, along with senior advisors, a fund advisor, and venture partners. Listed portfolio companies include Oncternal, Nabriva Therapeutics, Equillium, and MatriSys Bioscience, which is harnessing beneficial bacteria to treat inflammatory skin diseases.

New fund likely raising soon

The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.

01 · Says / Does

TagSaysDoes
StagesNot statedNot enough dated deals
SectorsDigital health, Biotech, Medical devices, Life sciences and research toolsNot enough dated deals
RegionsCANot enough dated deals

Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.

02 · Fund history

FundYearSizeStatus
Mesa Verde Venture Partners IV, LP
2022$7.58M (Form D)Late investment period

03 · People across funds

04 · Recent deals

No dated deals found yet.

05 · Latest from the firm

No news from the firm's website yet.

06 · Sources

  1. https://www.mesaverdevp.com
  2. https://www.mesaverdevp.com/
  3. https://www.mesaverdevp.com/blog

Fund dates and sizes are from SEC Form D filings.

Last verified: Oct 28, 2026